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Background: The purpose of this multicenter randomly controlled clinical trial was to compare two
acellular dermal matrix (ADM) materials produced by different processing techniques, freeze-dried
(FDADM) and solvent-dehydrated (SDADM) ADM, in their ability to correct Miller Class I and II recession
defects.
Methods: Eighty individuals from four study centers, each with a single maxillary anterior Miller Class I
or II recession defect were enrolled. Participants were randomly assigned and treated with coronally ad-
vanced flap (CAF) + FDADM (n = 42) or CAF + SDADM (n = 38). Gingival thickness, recession depth,
recession width, probing depth (PD), clinical attachment level, gingival index, plaque index, patient dis-
comfort, and wound healing index were recorded before surgery (day 0), immediately after surgery (day
1), and 2, 4, 12, 24, and 52 weeks postoperatively. The Student t test, paired t test, and Kruskal-Wallis
one-way ANOVA were used to analyze the data.
Results: When evaluating the clinical parameters after 1 year, both groups showed significant
(P <0.05) improvement for most of the parameters evaluated when compared to baseline (day 0). For
example, percentage of root coverage was 77.21% – 29.10% for CAF + FDADM and 71.01% – 32.87%
for CAF + SDADM. Conversely, no significant differences were observed between the two materials for
any clinical parameter tested or for patient satisfaction except PD on the mesial side of the defects
(P = 0.03).
Conclusions: Both FDADM and SDADM can be used successfully to correct Miller Class I or II reces-
sion defects. There were no statistically significant differences between groups for any of the clinical pa-
rameters tested. J Periodontol 2014;85:1693-1701.
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I
t is estimated that 23.8 million people (22.5%) in
the United States, aged >29 years, have gingival
recession (GR).1 The prevalence, extent, and se-
verity of GR increases with age.2 GR ismore prevalent
and severe at the facial surfaces of teeth.1 Thus, GR is
common in the United States adult population, and
appropriate measures to prevent or control this con-
dition are desirable.1
Coronally advanced flaps (CAFs) and combinations
of CAFs and other tissue grafts, such as subepithelial
connective tissue (CT), acellular dermalmatrix (ADM),
etc., all can be used to successfully treat GR.3-5 CAF
combined with subepithelial CT autograft has been the
gold standard for treating recession; however, the
morbidity associated with harvesting donor tissue from
a second surgical site led clinicians to seek other, less
invasive alternatives. To meet this challenge, ADM
was developed and has shown promising results.4,6-9
Two major types of ADM products are commercially
available: 1) freeze-dried (FDADM),i and 2) solvent-
dehydrated (SDADM).¶ In both processes, epidermis
and the cellular elements of dermis are removed to
provide a material consisting primarily of fibrillar col-
lagen mesh and elastin. According to the manufac-
turer, processing of FDADM begins with removal of the
epidermis using a buffered salt solution. Multiple cell
types within the dermis are then dissolved and washed
away using a non-denaturing detergent that rapidly
diffuses into the dermis. Finally, after a cryopreservant
is added to avoid damaging crystal formations, the
processed tissue matrix is freeze dried. For SDADM,
according to the manufacturer, the sterilization pro-
cess# gently removes unwanted materials, such as
cells, antigens, and viruses, and inactivated any path-
ogens.10 The steps in processing include osmotic,
oxidative, and alkaline treatment, solvent dehydration,
and limited-dose gamma irradiation for sterilization.
During solvent dehydration, the tissue is placed several
times in different gradations of acetone. At the end
of this step, acetone is left to evaporate in a vacuum
chamber. This results in dry tissue with residual water
content of <5% that can be stored at room temperature.
When used as a graft, ADM acts as a scaffold for new
tissue growth. Although ADM was used successfully to
treat recession defects, there has been only one direct
comparison of FDADM and SDADM for the treatment of
human GR defects reported in the literature.11
The purpose of this study is to evaluate whether
clinical parameters were improved by SDADM when
compared to FDADM for the treatment of Miller Class
I or II GR12 defects in a multicenter controlled, ran-
domized clinical trial (RCT).
MATERIALS AND METHODS
The study population consisted of patients with one
Miller Class I or II facial GR defect, ‡2 mm, located on
the facial aspect of a maxillary incisor, canine, or
premolar from four centers: 1) Center 3515: University
of Michigan School of Dentistry; 2) Center 3507,
Eastman Institute for Oral Health, University of
Rochester, New York; 3) Center 3514: University of
Alabama at Birmingham School of Dentistry; and 4)
Center 3508: Rutgers, The State University of New
Jersey. The Western Institutional Review Board (IRB)
and each center’s IRB approved this project, and the
study was conducted in accordance with the Helsinki
Declaration of 1975 as revised in 2000. All participants
gave written and verbal consent to participate. A power
analysis was conducted to determine the sample size
based on testing the difference of GR reduction from
baseline to 1 year between FDADM treatment and
SDADM treatment. Assuming there is no root cov-
erage status changes from 6 months to 1 year after
surgery, according to Novaes et al. (2001),13 it was
estimated the two treatment groups have a common
standard deviation (SD) of 1 mm. The sample size
ratio of the two groups was set as 1:1. It was determined
that a sample size of 34 per group would provide 80%
power to detect 0.7-mm difference between the group
means at a type I error rate of 0.05 using a two-sided
Student t test. Based on the power-size calculation, from
November 2009 to December 2010, a total of 80 in-
dividuals (26 males and 54 females, aged 23 to 74
years; mean age: 45.3 years) were enrolled in this
prospective RCT in four study centers. This multicenter
RCT is registered at clinicaltrials.gov as NCT00881959.
Participants were aged ‡18 years, able to un-
derstand and comply with all instructions, and able to
maintain good oral hygiene (O’Leary plaque score
£20%).14 Exclusion criteria included: 1) previous
surgery in the study area within the past 12 months;
2) antibiotic use exceeding 2 weeks duration within
the past 3 months; 3) allergy to any of the study
materials; 4) concomitant use of medications known
to cause gingival enlargement; 5) use of systemic
steroids; 6) unstable systemic diseases; 7) com-
promised immune function; 8) active infection; and
9) tobacco use within the past year. In addition, fe-
males who were pregnant or attempting to become
pregnant were excluded.
Participants were assigned randomly to one of two
treatment groups on the day of surgery: 1) CAF +
SDADM, or 2) CAF + FDADM. A third party (a
sponsor)** provided a box containing 20 sequential
randomization cards for each center in sealed en-
velopes. The FDADM group included 42 participants,
and the SDADM group included 38 participants,
with the non-significant difference being attributed to
i Alloderm, BioHorizons, Birmingham, AL.
¶ Puros Dermis, Zimmer Dental, Carlsbad, CA.
# Tutoplast process, Zimmer Dental.
** Zimmer Dental.
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randomization. All centers enrolled 20 patients, and
they are equally divided into 10 patients for each
group, except Center 3508, which had eight patients
in the SDADM group and 12 patients in the FDADM
group. The FDADM group had 26 (61.9%) females
and 16 (38.1%) males, whereas the SDADM group
had 28 (73.7%) females and 10 (26.3%) males.
Immediately before surgery, the surgeon drew an
envelope from the box and opened it to reveal the
treatment group for the patient. Randomization was
performed before surgery because the rehydration
process for the test and control ADMmaterials had to
be initiated before the surgical procedure started.
Rehydration of ADM materials was performed ac-
cording to the manufacturers’ instructions. SDADM
was hydrated for 5 to 30 minutes in endotoxin-free,
room-temperature 0.9% sterile saline. FDADM was
hydrated in two separate saline baths, 10 minutes
each, for a total of 20 minutes.
All surgeries were performed as described pre-
viously15 using CAF, periosteal release and blunt
dissection for tension-free closure, and the sling-and-
tag suturing technique. Surgeons (H-LW, GER, AS,
NCG, RME) from each center measured recession
depth (RD) (X) with a periodontal probe†† and then
used the same probe to create a bleeding point apical
to each adjacent gingival papilla at a distance equal
to the RD plus 1 mm (X + 1). Starting at the level of
the bleeding points, diverging vertical incisions were
made at mesio-facial and disto-facial line angles of
the study tooth. After connecting the vertical in-
cisions with a sulcular incision, a full-thickness mu-
coperiosteal flap was elevated several millimeters
beyond the mucogingival junction. An interproximal
knife‡‡ or 12B scalpel was then used to de-epithelialize
adjacent gingival papillae. The exposed root was
planed with curets, and any tissue tags were re-
moved from the flap and adjacent papillae with
curved iris scissors. Next, the periosteum was
scored near the base of the flap, and submucosal
tissues were undermined via blunt dissection with
a pair of scissors to allow coronal positioning of the
flap without tension, in the following manner: while
grasping the flap with tissue forceps and applying
gentle traction in a coronal and lateral direction, the
surgeon made a shallow horizontal incision through
the periosteum on the internal aspect of the flap, at
a level several millimeters apical to the vestibule.
Curved scissors§§ were inserted, with the tips closed,
into the incision in an apico-lateral direction, paral-
leling and undermining the vestibular fold, and then
were opened gently to bluntly separate the sub-
mucosal CTs and muscle fibers. This procedure was
repeated until the flap could be pulled coronally
without tension to a level that, in most cases, ap-
proximated the incisal edge or facial cusp tip of the
tooth. The surgeon then trimmed the rehydrated
ADM (SDADM or FDADM, depending on randomi-
zation) so that it was trapezoidal in shape, extended
at least 3 mm lateral and apical to the exposed root
surface when positioned at the cemento-enamel
junction (CEJ), and came no closer than 1 mm to the
vertical incisions outlining the recipient bed. The
ADM graft was secured to the test tooth at the level of
the CEJ with a single-sling, 5-0, fast-absorbing
polyglycolic-acid suture.ii The tissue flap was then
advanced to a level 1 to 2 mm coronal to the CEJ so
that the ADM was completely covered, and the flap
was secured with the sling-and-tag suture technique
with 5-0 polyglycolic-acid sutures as described
previously.15
At the time of surgery, each surgeon completed
a questionnaire regarding the handling characteris-
tics of the ADM grafting material used. Postoperative
medications included 600 mg ibuprofen every 6 to 8
hours as needed and 500 mg amoxicillin three times
daily for 10 days, starting 1 hour before surgery.
Patients were given 500 mg azithromycin 1 hour
before surgery and then 250 mg/d for 5 days if they
were allergic to amoxicillin. After surgery, patients
were instructed to rinse with warm salt water twice
daily, not to brush or floss the area until after the 14-
day postoperative visit or until the surgeon instructed
them to do so, restrict physical activity for 1 week, and
to eat a soft diet. Postoperative visits were scheduled
at 14 – 3, 30 – 7, 90 – 7, 180 – 14, and 365 – 14 days.
At the 14-day visit, the surgeon removed some or all
external sutures as he/she deemed appropriate. At
each postoperative visit, oral hygiene instructions
and professional cleaning were provided if plaque
accumulation was noted at the study site.
One calibrated, trained, masked examiner in each
center (Mary Layher, RDH, University of Michigan,
Ann Arbor, MI; Mary Therese Keating-Biltucci, RDH,
University of Rochester, Stony Brook, NY; Philip
Vassilopoulos, DDS, University of Alabama at Bir-
mingham School of Dentistry, Birmingham, AL;
Karen J. Pyra, RDH, Rutgers, The State University
of New Jersey, School of Medicine, Newark, NJ)
measured and recorded all clinical parameters. Ex-
aminers’ calibration revealed ‡70% interexaminer
agreement (–1 mm) and ‡90% intraexaminer
agreement (–1 mm)
Custom acrylic guides were fabricated to align
probing depth (PD), GR, and gingival thickness (GT)
measurements at the mid-facial aspect of the test
teeth. Plaque index,16 and gingival index17 were re-
corded before surgery and at each postoperative
†† UNC-15 periodontal probe, Hu-Friedy, Chicago, IL.
‡‡ Orban interproximal knife, Hu-Friedy.
§§ Metzenbaum scissors, Hu-Friedy.
ii Polyglycolic acid sutures, Ace Surgical Supply, Brockton, MA.
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visit. Wound healing index18 and patient discomfort
level (1 = mild, 2 = mild to moderate, 3 = moderate,
4 = moderate to severe, 5 = severe) were recorded at
each postoperative visit. RD and recession width
(RW) were recorded before surgery, after suturing,
and at each postoperative visit. Percentage of root
coverage was a mathematic calculation taken directly
from the mid-facial measurement before treatment
versus after treatment. PD, clinical attachment level
(CAL, equal to PD + RD), and GT were measured at
baseline (before surgery) and at the 90-, 180-, and
365-day visits. After applying a topical anesthetic,
GT was measured mid-facially, 1 and 3 mm apical to
the gingival margin, by penetrating the soft tissue
with an endodontic broach that had an attached
rubber stopper. GT measurements were then calcu-
lated to the nearest 0.5 mm using a metal ruler. All
other clinical measurements were made using a
calibrated periodontal probe. To assess patient sat-
isfaction, patients filled out a patient quality as-
sessment form at the 180- and 365-day visits.
Demographic information, baseline information,
and outcome clinical parameter follow-up assess-
ments were summarized by the descriptive statistics
chosen appropriate to the data scale. Continuous
data were summarized by mean, SD, sample size (n),
minimum, and maximum. Categoric data were
summarized by frequency and percentage. Student t
test was used to compare the primary clinical out-
come parameters between FDADM treatment and
SDADM treatment. Paired t test was used to evaluate
the primary clinical outcome parameter improve-
ment from baseline to 1 year within each treatment
group. Kruskal-Wallis one-way ANOVA was applied
to examine the variations of the primary clinical out-
come parameters caused by the different clinical
centers. Post hoc pairwise comparisons with P values
adjusted for family-error rate were provided to identify
the particular significant difference between the dif-
ferent centers.
RESULTS
Mean age was 47.4 – 14.0 and 43.0 – 13.0 years for
FDADM and SDADM, respectively. There was no
statistically significant difference in the distribution of
Miller Class defects between groups, the majority
being Miller Class I. In addition, approximately half of
the teeth treated in each group were maxillary canines.
Most of the patients in both groups showed good to
excellent oral hygiene throughout the study. Table 1
presents the enrolled participants’ demographic
information and defect characteristics. Figures 1
and 2 illustrate a patient treated with each processed
membrane.
With regard to adverse events, only minimal
complications were reported during the study period.
Only one patient in each group reported graft ex-
posure and infection. Interestingly, one patient in the
SDADM group reported paresthesia after surgery;
however, it was resolved during the follow-up period.
When evaluating the clinical parameters after
1 year, significant differences were found within groups
for most of the parameters evaluated (Table 2). Both
groups had significant (P <0.05) RD reduction (2.00 –
0.87 mm for FDADM and 2.06 – 1.11 mm for
SDADM) and percentage of root coverage (77.21% –
29.10% and 71.01% – 32.87% for FDADM and
SDADM, respectively; P <0.0001) when compared to
baseline. Both groups showed a significant increase
in CAL (P <0.0001), with -1.69 – 1.08 and -1.57 –
1.19 mm for FDADM and SDADM, respectively.
Conversely, no significant differences were ob-
served between the two treatment groups except
PDs on the mesial side of the defects (P = 0.03), with
2.63 – 0.63 and 2.33 – 0.57 mm for FDADM and
SDADM, respectively. Although statistically significant,
the clinical significance of this 0.3-mm difference could
Table 1.
Demographic Information of the Study
Variable FDAMD (n = 42) SDAMD (n = 38)
Sex
Males 38.1% (16) 26.3% (10)
Females 61.9% (26) 73.7% (28)
Age (years) (mean – SD) 47.4 – 14.0 43.0 – 13.0
Miller’s Class
I 88.1% (37) 84.2% (32)
II 11.9% (5) 15.8% (6)
Oral hygiene level
Excellent 40.5% (17) 55.3% (21)
Fair 2.4% (1)
Good 57.1% (24) 44.7% (17)
Race
African American 4.8% (2)
Asian 2.4% (1) 5.3% (2)
White 73.8% (31) 84.2% (32)
Hispanic 11.9% (5) 7.9% (3)
Other 7.1% (3) 2.6% (1)
Tooth #
4 7.9% (3)
5 19.0% (8) 23.7% (9)
6 33.3% (14) 18.4% (7)




11 19.0% (8) 31.6% (12)
12 19.0% (8) 10.5% (4)
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be questioned. There were no significant differences
between groups for CAL, GT, PD, RD, RW, and width of
keratinized tissue (KT). Table 3 shows results of the
surgeons’ questionnaire regarding handling character-
istics of the two test materials. There were no statisti-
cally significant differences between groups for any
parameters except ease of handling, in which SDADM
scored higher than FDADM, at 97.4% and 73.8%, re-
spectively.
When center effect was examined (see supple-
mentary Table 1 in online Journal of Periodontology),
all four centers achieved similar clinical outcomes
Figure 1.
A patient treated with SDADM. A) Tooth #11 presents 3-mm Miller’s Class I facial GR. B) The flap was reflected using a full-thickness flap with two
divergent vertical releasing incisions. C) SDADM was trimmed to cover 3 mm beyond the recession defect and then secured with single-sling sutures.
D) The flap was coronally advanced following the sling-and-tag suturing technique.15 E) Four weeks after surgery, there was good soft-tissue healing
and recession defect coverage. F) Twelve months after surgery, there was 100% recession defect coverage.
Figure 2.
A patient treated with FDADM. A) Tooth #12 presents 3.5-mm Miller’s Class I facial GR. B) The flap was reflected using a full-thickness flap with two
divergent vertical releasing incisions.C) FDADMwas trimmed to cover at least 3 mmbeyond the recession defect and then secured with single-sling sutures.
D) The flap was coronally advanced following the sling-and-tag suturing technique.15 E) Four weeks after surgery, there was good soft-tissue healing and
recession defect coverage. F) Twelve months after surgery, there was 100% recession defect coverage.
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between both groups with two exceptions. Center
3507 achieved significantly greater mesial PD re-
duction compared to Center 3514, and Center 3508
achieved significantly increased GT compared to
Center 3514.
DISCUSSION
To date, there has been limited published information
related to the influence of ADM manufacturing pro-
cesses on clinical outcomes.11 Results from the
present study show that there were no differences in
clinical outcomes between SDADM and FDADM for
root coverage of Miller Class I or II GR defects. Both
processed ADM materials achieved significant re-
duction of RD (average 2 mm) and gained >70%
root coverage. This is in agreement with a previously
published report in which both ADMs were compared
in a 6-month study, although Miller Class III recession
defects were also included in this study.11 In that
study, mean recession/percentage coverage were 2.83
mm/81.4% and 3.13 mm/83.4% root coverage in
SDADM and FDADM, respectively.11 Findings from the
present study clearly indicated that the outcomes of
root coverage in Miller Class I or II recession defects
were not related to ADM processing techniques. In
addition, the slightly lower percentage of root coverage
achieved in the present investigation might be attrib-
utable to the surgical approach; an open approach is
used which might jeopardize the blood supply and
cause another surgical trauma that may induce tissue
Table 2.




(mm; mean – SD)
12 Months
(mm; mean – SD)
Differences
(mm; 12 months to baseline) P
CAL
FDADM 4.04 – 0.85 2.34 – 1.10 -1.69 – 1.08 <0.0001
SDADM 3.99 – 1.04 2.44 – 1.22 -1.57 – 1.19 <0.0001
GT 1 using stent (at 3 mm apical to the CEJ)
FDADM 0.74 – 0.86 1.79 – 0.62 0.99 – 0.83 <0.0001
SDADM 1.12 – 0.87 1.73 – 0.59 0.66 – 0.90 0.0001
GT 2 using stent (at 1 mm apical to
the free gingival margin)
FDADM 1.21 – 0.56 1.72 – 0.40 0.50 – 0.69 <0.0001
SDADM 1.30 – 0.47 1.58 – 0.44 0.32 – 0.70 0.0095
PD distal
FDADM 2.60 – 0.55 2.57 – 0.52 -0.04 – 0.62 0.6916
SDADM 2.38 – 0.63 2.58 – 0.55 0.18 – 0.72 0.1407
PD mesial
FDADM 2.68 – 0.60 2.63 – 0.63 -0.04 – 0.58 0.6742
SDADM 2.42 – 0.50 2.33 – 0.57 -0.11 – 0.56 0.2435
PD mid
FDADM 1.34 – 0.55 1.80 – 0.60 0.46 – 0.60 0.0002
SDADM 1.28 – 0.49 1.64 – 0.54 0.35 – 0.56 0.0007
RD
FDADM 2.73 – 0.71 0.72 – 1.00 2.00 – 0.87 <0.0001
Percentage of root coverage 77.21% – 29.10%
SDADM 2.91 – 1.01 0.88 – 1.02 2.06 – 1.11 <0.0001
Percentage of root coverage 71.01% – 32.87%
RW
FDADM 3.49 – 0.99 1.05 – 1.47 -2.51 – 1.27 <0.0001
SDADM 3.47 – 0.73 1.40 – 1.58 -2.08 – 1.56 <0.0001
Width of KT
FDADM 3.29 – 1.49 3.91 – 1.81 0.55 – 1.45 0.0256
SDADM 2.93 – 1.76 3.60 – 1.65 0.72 – 1.07 0.0003
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shrinkage during healing when compared to the tunnel
approach. Currently, there is no study comparing the
effect of the ADM processing under the tunnel surgical
approach. Future research in this area is encouraged.
Other factors that may influence current surgical ap-
proach outcomes were addressed in several recent
systematic reviews.19-21 These include, but are not
limited to, the following: 1) failure to identify CEJ before
surgery; 2) different adjacent papillae dimension; 3)
different degree of root prominence; 4) full-thick-
ness instead of partial-thickness approach; 5) flap
stability; 6) flap mobility; and 7) suturing. When the
surgeon failed to control these factors, poor clinical
outcomes are often anticipated.19-21
Table 3.
Comparison of Handling Properties Between FDADM and SDADM
Variable Value Statistical Summary P
How would you rate the ability to handle and
manipulate the hydrated product? (easy,
somewhat difficult, very difficult)
0.004
FDADM Easy 73.8% (31 of 42)
SDADM Easy 97.4% (37 of 38)
How did the product adapt to the contours of the
grafted site? (easily adapted, somewhat difficult
to adapt, very difficult to adapt)
0.362
FDADM Easily adapted 90.5% (38 of 42)
SDADM Easily adapted 97.4% (37 of 38)
How would you rate the ability to hydrate the product?
(easy, somewhat difficult, very difficult)
0.092
FDADM Easy 81.0% (34 of 42)
SDADM Easy 94.7% (36 of 38)
Did the edges of the product fray when trimmed?
(yes, no, did not trim)
0.092
FDADM No 81.0% (34 of 42)
SDADM No 94.7% (36 of 38)
Did the product remain in place during closure? (yes, no) 0.242
FDADM Yes 92.9% (39 of 42)
SDADM Yes 100.0% (38 of 38)
Did the product stick to your gloves or instruments
during handling and manipulation? (yes, no)
0.117
FDADM No 90.5% (38 of 42)
SDADM No 100.0% (38 of 38)
Did the product stick to itself during handling and
manipulation? (yes, no)
0.242
FDADM No 92.9% (39 of 42)
SDADM No 100.0% (38 of 38)
If stabilization was necessary, how did the product
respond to sutures? (easily stabilized, slightly
difficult to stabilize, very difficult to stabilize)
0.269
FDADM Easily stabilized 85.7% (36 of 42)
SDADM Easily stabilized 94.7% (36 of 38)
How did the product maintain its structural integrity
during manipulation and handling? (remained
intact, exhibited slight thinning, exhibited
thinning and structural compromise)
0.242
FDADM Intact 92.9% (39 of 42)
SDADM Intact 100.0% (38 of 38)
Statistical data are presented as % of total (n of total).
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Data from the present study show that both treat-
ments improved CAL (1.7mm for FDADMand 1.6mm
for SDADM), increased tissue thickness at 1 and 3 mm
apical to the free gingival margin (range from 0.3 to
1.0 mm), and augmented KT width (0.6 to 0.7 mm).
These results corroborate previous ADM studies15,22-24
that showed ADM achieved predictable root coverage
and increased GT. Interestingly, a recent systematic
review concluded that studies adding ADM under
CAF demonstrated a great heterogeneity and no sig-
nificant benefits compared to CAF alone.21 However,
they suggested that more studies with longer follow-up
are needed to further evaluate the usage of this material
under CAF.
It is likely that both ADM materials yielded com-
parable surgical results because both have a similar
collagen matrix structure, which allows easy pene-
tration of new vascular systems into open channels
and integration into existing host tissue.25 In addition,
Cummings et al.,26 in a human histologic study,
showed that grafted ADM formed an attachment
directly to the root surface through a combination of
CT adhesion and long junctional epithelium which, in
turn, increased the tissue thickness.
The present study also finds that both KT and PD
remained stable during the 12-month period and that
ADM slightly increased the zone of KT, which is in
agreement with findings reported previously by
Woodyard et al.27 The fact that root coverage occurred
without PD change with time implied that a new at-
tachment, such as long junctional epithelium and CT
attachment, might have been established. It is impor-
tant to note that the mesial and distal PD were recorded
without a custom surgical guide, and this might cause
some inconsistent recordings. Nonetheless, the present
findings also agree with a recent clinical study by
Barker et al.11 that showed no difference in root cov-
erage when using SDADM versus FDADM. Both find-
ings are supported by the histologic report that showed
that both SDADM- and FDADM-processed materials
retained more natural architecture and physical prop-
erties than other material.¶¶28 Hence, it may imply the
long-term stability of ADM treatment.
In this study, minimal complications are noted in
bothmaterials, which implies that ADM, regardless of
processing, is a safe material to use in patients. This
finding is supported bymany previous reports.3-8 In this
study, the most commonly reported complications are
graft exposure and graft infection, with only one case
in each treatment group. In the SDADM group, the
complication was successfully treated with antibi-
otics and antimicrobial mouth rinse. In the FDADM
group, surgical debridement and revision, antibiotics,
and mouth rinse were used to successfully treat the
graft exposure and infection. Healing with ADM be-
gins with preserved proteoglycans and proteins di-
recting the patient’s own cells to initiate revascularization
and cell repopulation. Significant revascularization is
observed after 7 to 10 days as fibroblasts begin tissue
remodeling.29 At 45 days, CT forms through host col-
lagen deposition and the ADM is repopulated with cells
and remodels during the next 3 to 6 months.29 If the
ADM is left exposed, as in the case of free gingival
grafting, the ADM matrix will support epithelial cell
migration.28 Although the complication incidence was
low, it is important to recognize these possible compli-
cations and learn how to deal with them properly. In
addition, both materials handle almost identically,
except SDADM showed better ease-of-handling
characteristics than FDADM. This might be because
the SDADM processing preserves the original dermis
structure, and, by using chemical agents to de-
hydrate the material, it eliminates the need for
preserving the material in antibiotic solution under
freeze-dried conditions. As a result, no dual hydra-
tion/dilution is needed before the clinical usage. As
the result, no defreezing is needed before the clinical
usage. This is somewhat supported by the study
published by Hinton et al.,30 who demonstrated that
SDADM-processed fascia lata works better as
a grafting material than FDADM obtained from tissue
banks. Nonetheless, it has to be cautioned that fascia
lata is not the same material as dermis, although the
same material processing techniques were used.
Interestingly, results from this study show that
there was no difference among the four centers. This
suggested that, by adhering to the surgical protocol,
clinical outcomes were predictable, no matter who
the operator. Nonetheless, to ensure that the proper
surgical technique was used among centers, pre-
study training was conducted to ensure that similar
surgical approaches were performed. This might
explain why there was no center effect.
CONCLUSIONS
Within the limitations of this study, both FDADM
and SDADM can be successfully used to correct Miller
Class I or II recession defects with equivalent outcomes.
There were no statistically significant differences among
groups for any of the clinical parameters tested.
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